Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS

Journal of Clinical Child and Adolescent Psychology

Volumn 44, Issue 6, 2015, Pages 985-991

  Halldorsdottir, Thorhildur ^a   Ollendick, Thomas H ^a   Ginsburg, Golda ^b   Sherrill, Joel ^c   Kendall, Philip C ^d   Walkup, John ^e   Sakolsky, Dara J ^f   Piacentini, John ^g  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ANXIETY DISORDERS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE CONTROL STUDY; CHILD; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ANXIETY DISORDERS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; COGNITIVE THERAPY; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84943199399     PISSN: 15374416     EISSN: None     Source Type: Journal    
DOI: 10.1080/15374416.2014.952008     Document Type: Article

References (33)

1. S.R.Anderson, & T.H.Ollendick, (2012). Diagnosing oppositional defiant disorder using the Anxiety Disorders Interview Schedule for DSM-IV: Parent Version and the Diagnostic Interview Schedule for Children. Journal of Psychopathology and Behavioral Assessment, 34, 467–475.
2. A.Angold,, E.J.Costello, & A.Erkanli, (1999). Comorbidity. Journal of Child Psychology and Psychiatry, 40, 57–87.
3. S.L.Berman,, C.F.Weems,, W.K.Silverman, & W.M.Kurtines, (2000). Predictors of outcome in exposure-based cognitive and behavioral treatments for phobic and anxiety disorders in children. Behavior Therapy, 31, 713–731.
4. J.Biederman,, J.Newcorn, & S.Sprich, (1991). Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. American Journal of Psychiatry, 148, 564–577.
5. R.Bowen,, D.A.Chavira,, K.Bailey,, M.T.Stein, & M.B.Stein, (2008). Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Research, 157, 201–209.
6. G.L.Canivez, & M.W.Watkins, (1998). Long-term stability of the Wechsler Intelligence Scale for Children (3rd ed.). Psychological Assessment, 10, 285–291.
7. S.N.Compton,, T.S.Peris,, D.Almirall,, B.Birmaher,, J.Sherrill,, P.C.Kendall, … A.M.Albano, (2014). Predictors and moderators of treatment response in childhood anxiety disorders: Results from the CAMS trial. Journal of Consulting and Clinical Psychology, 82, 212–224. doi:10.1037/a0035458
8. S.N.Compton,, J.T.Walkup,, A.M.Albano,, J.C.Piacentini,, B.Birmaher,, J.T.Sherrill,, … J.March, (2010). Child/adolescent anxiety multimodal study (CAMS): Rationale, design, and methods. Child and Adolescent Psychiatry and Mental Health, 4, 1–15.
9. E.Flannery-Schroeder,, C.Suveg,, S.Safford,, P.C.Kendall, & A.Webb, (2004). Comorbid externalizing disorders and child anxiety treatment outcomes. Behaviour Change, 21, 14–25.
10. G.Ginsburg,, P.C.Kendall,, D.Sakolsky,, S.N.Compton,, J.Piacentini,, A.M.Albano, … B.Birmaher, (2011). Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS. Journal of Consulting and Clinical Psychology, 79, 806–813.
11. J.B.Grayson,, E.B.Foa, & G.S.Steketee, (1982). Habituation during exposure treatment: Distraction vs. attention-focusing. Behavior Research and Therapy, 20, 323–328.
12. J.B.Grayson,, E.B.Foa, & G.S.Steketee, (1986). Exposure in vivo of obsessive-compulsives under distracting and attention-focusing conditions: Replication and extension. Behavior Research and Therapy, 24, 475–479.
13. W.Guy, (1976). Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacotherapy. Rockville, MD: National Institute for Mental Health.
14. T.Halldorsdottir,, M.A.Jarrett, & T.H.Ollendick, (2013, November). ADHD and sluggish cognitive tempo symptoms as predictors of treatment response for specific phobias in youth. In S. Becker & S. Marhall (Co-Chairs) Sluggish Cognitive Tempo in Youth and Adults: Relations to ADHD, Internalizing Disorders, Impairment, and Treatment Response. Symposium presented at the 47th annual meeting of the Association for Behavioral and Cognitive Therapies, Nashville, TN.
15. T.Halldorsdottir, & T.H.Ollendick, (2013). Comorbid ADHD: Implications for the treatment of anxiety disorders in children and adolescents. Cognitive and Behavioral Practice, 21, 310–322.
16. M.A.Jarrett, & T.H.Ollendick, (2008). A conceptual review of the comorbidity of attention-deficit/hyperactivity disorder and anxiety: Implications for future research and practice. Clinical Psychology Review, 28, 1266–1280.
17. M.A.Jarrett, & T.H.Ollendick, (2012). Treatment of comorbid attention-deficit/hyperactivity disorder and anxiety in children: A multiple baseline design analysis. Journal of Consulting and Clinical Psychology, 80, 239–244.
18. M.A.Jarrett,, J.C.Wolff, & T.H.Ollendick, (2007). Concurrent validity and informant agreement of the ADHD module of the Anxiety Disorders Interview Schedule for DSM–IV. Journal of Psychopathology and Behavioral Assessment, 29, 159–168.
19. P.S.Jensen,, S.P.Hinshaw,, H.C.Kraemer,, N.Lenora,, J.H.Newcorn,, H.B.Abikoff,, … B.Vitiello, (2001). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 147–158.
20. P.C.Kendall,, E.U.Brady, & T.L.Verduin, (2001). Comorbidity in childhood anxiety disorders and treatment outcome. Journal of American Child & Adolescent Psychiatry, 40, 787–794.
21. P.C.Kendall,, S.N.Compton,, J.T.Walkup,, B.Birmaher,, A.M.Albano,, J.Sherrill,, … J.Piacentini, (2010). Clinical characteristics of anxiety disordered youth. Journal of Anxiety Disorders, 24, 360–365.
22. H.C.Kraemer,, T.Wilson,, C.G.Fairburn, & S.Agras, (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry, 59, 877–883.
23. K.Larson,, S.A.Russ,, R.S.Kahn, & N.Halfon, (2011). Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics, 127, 462–470.
24. K.Levy,, C.Hunt, & S.Heriot, (2007). Treating comorbid anxiety and aggression in children. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1111–1118.
25. K.Manassis,, S.Mendlowitz,, D.Scapillato,, D.Avery,, L.Fiksenbaum,, M.Freire,, … M.Owens, (2002). Group and individual cognitive-behavioral therapy for childhood anxiety disorders: A randomized trial. Journal of American Academy of Child and Adolescent Psychiatry, 41, 1423–1430.
26. T.H.Ollendick,, M.A.Jarrett,, A.E.Grills-Taquechel,, L.D.Hovey, & J.C.Wolff, (2008). Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders. Clinical Psychology Review, 28, 1447–1471.
27. R.M.Rapee,, H.J.Lyneham,, J.L.Hudson,, M.Kangas,, V.M.Wuthrich, & C.A.Schniering, (2013). Effect of comorbidity on treatment of anxious children and adolescents: Results from a large, combined sample. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 47–56.
28. Research Units on Pediatric Psychopharmacology Anxiety Study Group. (2003). Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 13–21.
29. W.K.Silverman, & A.M.Albano, (1996). Manual for the ADIS–IV–C/P. New York, NY: Psychological Corporation.
30. M.A.Southam-Gerow,, P.C.Kendall, & V.R.Weersing, (2001). Examining outcome variability: Correlates of treatment response in a child and adolescent anxiety clinic. Journal of Clinical Child Psychology, 30, 422–436.
31. E.A.Storch,, L.J.Merlo,, M.J.Larson,, G.R.Geffken,, H.D.Lehmkuhl,, M.L.Jacob,, … W.K.Goodman, (2008). Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 583–592.
32. J.T.Walkup,, A.M.Albano,, J.Piacentini,, B.Birmaher,, S.N.Compton,, J.T.Sherrill,, … P.C.Kendall, (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.
33. D.Wechsler, (1991). Manual for the Wechsler Intelligence Scale for Children (WISC–III). San Antonio, TX: Psychological Corporation.